Trump Plan for Tariffs on Imported Drugs Draws Criticism on All Sides

(MedPage Today) — President Trump’s plan to levy tariffs on imported pharmaceuticals is drawing criticism from all sides of the political spectrum.
“Domestic manufacturing matters, but doing it by taxing patients through tariffs is the wrong…

Source link : https://www.medpagetoday.com/publichealthpolicy/healthpolicy/116891

Author :

Publish date : 2025-08-07 20:58:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Trump Plan for Tariffs on Imported Drugs Draws Criticism on All Sides

More Evidence Linking Firefighting to Increased Cancer Mortality Risk

Harvard Scientists Say Research Could Be Set Back Years After Funding Freeze

Related Posts

Many People Without Celiac Disease Report Gluten, Wheat Sensitivity

Mixed Results With Metformin for Men on ADT for Prostate Cancer

Difficult-to-Treat Rheumatoid Arthritis: Is Prevention Feasible?

Dual GIP/GLP-1 Drug Linked to Fewer Deaths in Real-World Liver Disease Study

Modestly Higher Risk for Autoimmune Disease Linked to HT

Delaying Gallbladder Removal After Bile Duct Stones May Be Riskier

Many People Without Celiac Disease Report Gluten, Wheat Sensitivity

Mixed Results With Metformin for Men on ADT for Prostate Cancer

Difficult-to-Treat Rheumatoid Arthritis: Is Prevention Feasible?

Dual GIP/GLP-1 Drug Linked to Fewer Deaths in Real-World Liver Disease Study

Modestly Higher Risk for Autoimmune Disease Linked to HT

Delaying Gallbladder Removal After Bile Duct Stones May Be Riskier

First 7-Year Report of Low-Risk TAVR Reassures, With Finish Line Now in Sight

Pre-op Immunotherapy for Head and Neck Cancer Rising

Categories

Archives